Peter Thall

18PUBLICATIONS

66CO-AUTHORS

NanomedicineTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jul 05, 2026

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

|Apr 20, 2026

BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing Changes.

|Aug 25, 2025

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Yago Nieto, John F Ward, Wayne Hofstetter

|Jun 26, 2025

Practical Bayesian Guidelines for Small Randomized Oncology Trials.

Peter F Thall

|Jan 13, 2025

Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.

Yago Nieto, Jeremy Ramdial, Benigno Valdez

|Apr 04, 2024

Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project Optimus.

Peter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages

Pageof 3

Frequent Collaborators

Ying Yuan

Pavlos Msaouel

Roland Bassett

Moreno Ursino

Andrew G Chapple

Melissa Barnett

Jeremy Ramdial

Yago Nieto

Yong Zang

Ruitao Lin

Frequent Collaborators

Ying Yuan

Pavlos Msaouel

Roland Bassett

Moreno Ursino